Länsförsäkringar

Phenaros Pharmaceuticals is a Swedish spin-off drug discovery company from Uppsala University. We employ phenomics (large-scale cell morphological profiling) in conjunction with automation and AI to discover and repurpose medications for uncommon diseases. Aside from developing an in-house drug discovery pipeline, we also form collaborations to provide access to our discovery platform.

Swedish Logistic Property specializes in the development and management of logistics properties throughout Sweden. The company focuses on energy efficiency and provides modern logistics solutions tailored to the needs of diverse businesses. Its portfolio features strategically located properties that facilitate efficient logistics and supply chain operations. In addition to managing existing assets, Swedish Logistic Property actively engages in the acquisition and development of new properties to expand its presence in the logistics real estate market. The company demonstrates a strong commitment to sustainability through its construction practices and the operation of its logistics facilities.

Swedish Logistic Property specializes in the development and management of logistics properties throughout Sweden. The company focuses on energy efficiency and provides modern logistics solutions tailored to the needs of diverse businesses. Its portfolio features strategically located properties that facilitate efficient logistics and supply chain operations. In addition to managing existing assets, Swedish Logistic Property actively engages in the acquisition and development of new properties to expand its presence in the logistics real estate market. The company demonstrates a strong commitment to sustainability through its construction practices and the operation of its logistics facilities.

Adenovir Pharma AB is a development company developing new solutions for treatment of infectious diseases affecting the eyes. Adenovir Pharma was founded by researchers at the department of Virology, Umeå University, Sweden and P.U.L.S. AB which acts as an incubator and financer for early stage projects within life science. Adenovir Pharma is located in Helsingborg Sweden in one of Europe’s premier biotechnology regions, Medicon Valley. The initial development has been conducted at the University of Lund, Department of Organic Chemistry and at the University of Umeå, Department of Virology and in collaboration with P.U.L.S. AB and external service providers. With unique patented technology and own product concepts, Adenovir Pharma aim to offer new treatments and business development opportunities to the pharmaceutical industry. The goal is to develop a new antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC).